x
ServiziMenu principaleHome
You are here: Home > Events > Future Events > 6th ESO-ESMO Latin-American Masterclass in Clinical Oncology
Print

6th ESO-ESMO Latin-American Masterclass in Clinical Oncology

22.04.2020  -  26.04.2020

Buenos Aires, Argentina

MASTERCLASS

Medical/Clinical Oncology

Description

Chairs: A. Cervantes, ES - N. Pavlidis, GR - R.A. Stahel, CH
Scientific Co-ordinators: M. Aapro, CH - F. Cardoso, PT



FOREWORD
The Masterclass is the most structured ESO educational activity whose format has been established and presented in Europe for over a decade. The success of the teaching method has been confirmed by the events held also in other parts of the world as well as by the five editions held in Latin America. It is with pleasure and gratefulness for the consideration of the local community, that ESO announces the sixth edition to be held in the region in 2020.The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited.
Participants will deliver case presentations within tumour boards and small groups and discuss them with the experts.
As for all Masterclasses, the number of participants will be limited and admission will be by competitive application only.
Admitted participants will be granted free registration and half-board accommodation for the duration of the Masterclass.

TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages. The clinical sessions will be complemented by tumour board discussions supported by regional tutors.
Furthermore, participants will deliver case presentations within small groups and discuss these with the experts.
In preparation of the attendance, participants will be requested to follow four selected e-ESO sessions (www.e-eso.net).
All participants will reside at the course venue and participation is compulsory throughout the course.
The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.

LEARNING OBJECTIVES
• Improve medical oncologists’ skills
• Practicing case discussion
• Deep focus on breast, gastro-intestinal, genitourinary, gynaecological, head and
neck and lung cancers
• Compact update on further topics of interest

MAIN TOPICS
• Breast cancer
• Gastro-intestinal cancers
• Genito-urinary cancers
• Gynaecological cancers
• Head and neck cancer
• Lung cancer

The Latin-American
Masterclass in
Clinical Oncology is an
ESO-ESMO joint event
         
In collaboration with          
Under the auspices of          

        

          

 

In this review, the authors summarize the history of the 41 Masterclasses in Clinical Oncology (MCO) organized by ESO or ESO-ESMO during the last 17 years. The MCO has become a major educational event of ESO, intending to educate young oncologists from various countries within or outside Europe, providing an up-to-date interactive program based on solid evidence for all presented topics.
"Reprinted from Critical Reviews in Oncology / Hematology, Pavlidis et al, Copyright (2019)
https://doi.org/10.1016/j.critrevonc.2019.07.022 with permission from Elsevier”

Download PDF document

Faculty

FACULTY (as of December 2019)
M.S. Aapro, Clinique de Genolier, Genolier, CH
F. Cardoso, Champalimaud Cancer Center, Lisbon, PT
F. Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, CH
A. Cervantes, University Clinical Hospital, Valencia, ES
M. Chacon, Instituto Alexander Fleming, Buenos Aires, AR
G. Curigliano, European Institute of Oncology, Milan, IT
F. Esteso, Instituto Alexander Fleming, Buenos Aires, AR
S.X. Franco, Clinical del Country, Bogota, CO
G.H. Giornelli, Instituto Alexander Fleming, Buenos Aires, AR
S. Iseas, Hospital Udaondo, Buenos Aires, AR
D. Lorusso, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT
C. Martin, Instituto Alexander Fleming, Buenos Aires, AR
N. Mottet, University Jean Monnet, Saint Etienne, FR
J. Nadal, Instituto Alexander Fleming, Buenos Aires, AR
N. Pavlidis, University Hospital, Ioannina, GR
F.A. Peccatori, European School of Oncology and European Institute of Oncology, Milan, IT
F. Penault-Llorca, Centre Jean Perrin, Clermont-Ferrand, FR
C. Rolfo, University of Maryland School of Medicine, Baltimore, US
J.P. Sadé, Instituto Alexander Fleming, Buenos Aires, AR
C. Sessa, Oncology Institute of Southern Switzerland, Bellinzona, CH
R.A. Stahel, University Hospital, Zurich, CH
E. Van Cutsem, University Hospital Gasthuisberg, Leuven, BE
J.J. Zarbá, Hospital Zenon Santillan, San Miguel de Tucuman, AR

General information

ORGANISING SECRETARIAT
European School of Oncology
Piazza Indipendeza 2, 6500 Bellinzona, Switzerland
Luis Carvalho, Ph: +41 91 820 09 58, E-mail: lcarvalho@eso.net
Laura Richetti, Ph +41 91 820 09 51, E-mail: lrichetti@eso.net

LANGUAGE
The Masterclass will be held in English and translation will not be provided.

INSURANCE
The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.

CME AND ESMO MORA ACCREDITATION AND CERTIFICATES
The 6th ESO-ESMO Latin-American Masterclass in Clinical Oncology, Buenos Aires, Argentina, 22/04/2020-26/04/2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
The programme has been granted up to 32 European CME credits (ECMEC) . Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
Participants will be entitled to receive a certificate of attendance at the close of the event by completing the on-line evaluation questionnaire.
Furthermore, application for the ESMO-MORA points is in process.

Application

PARTICIPANT’S PROFILE
• Age between 30 and 40 years
• At least 3 years’ experience in medical oncology (or clinical oncology)
• Involvement in scientific activities (desirable)
• Intermediate level of English language
• Practicing in Latin America

The application outcome will be notified by e-mail by begin of February.

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY
Successful applicants are granted free registration and half-board accommodation.
THE APPLICATION DEADLINE HAS PASSED (19 JANUARY 2020)

Programme

22 April

12:15   Welcome and introduction      
Chairs            
12:30   Clinical session Gynaecological Cancers
Chair: C. Sessa, CH - Co-Chair: TBC
    Pathologist's impact in gynaecological tumour
F. Penault-Llorca, FR
    Discussion
    Ovarian Cancer: Surgical and systemic treatment
D. Lorusso, IT
    Discussion
    Endometrial Cancer: Local and systemic treatment
C. Sessa, CH
    Discussion
    Cervical Cancer: Local and systemic treatment
D. Lorusso, IT
    Discussion
14:30   Coffee break
14:50   Spotlight session Primary and secondary prevention of cervical cancer
J.J. Zarbá, AR
15:10   Discussion
15:20   Selected participants present their national situation ("How is cancer treated in my country")
15:30   Discussion
15:40   Tumour board Gynaecological Cancer
C. Sessa,CH - D. Lorusso, IT
Local Tutors: G. Giornelli, AR - TBC
Participants' case presentations
16:40   Group sessions Clinical case presentations by participants
Chairs 1: C. Sessa, CH - Co-chair: TBC
Chair 2: D. Lorusso, IT - Co-chair: TBC
17:40   The role of surgery in ovarian cancer - Video session
18:20   Discussion
20:00   Welcome dinner

 

 23 April

8:30   Clinical session Breast cancer (I)
Chair: F. Cardoso, PT - Co-Chair: TBC
    What the clinician needs to know about breast pathology and sample quality
F. Penault-Llorca, FR
    Genomic tests in clinical practice
F. Cardoso, PT
    Discussion
    (Neo-) adjuvant chemotherapy and biological agents
G. Curigliano, IT
    Discussion
    Neoadjuvant/adjuvant endocrine therapy
F. Cardoso, PT
    Discussion
 10:35   Coffee break   
10:50   Spotlight session The reality of clinical trials in Latin America
C. Rolfo, US
 10:10   Discussion
 11:20   Clinical session Breast cancer (II)
Chair: G. Curigliano - Co-Chair: TBC
    Recommended management of HER-2+ advanced breast cancer
F. Cardoso, PT
    Discussion
    Recommended management for triple-negative advanced breast cancer
G. Curigliano, IT
    Discussion
    Recommended management for ER+ advanced breast cancer
S.X. Franco, CO
    Discussion
13:05   Lunch
14:00   Tumour board Breast cancer
F. Cardoso, PT - G. Curigliano, IT - S.X. Franco, CO
Local tutor: J. Nadal, AR
Participant's case presentations
16:00   Coffee break
16:15   Group sessions
Chair 1: F. Cardoso, PT - Co-Chair: J. Nadal, AR
Chair 2: G. Curigliano, IT - S.X. Franco, CO
Clinical case presentations by participants
18:00   Spotlight session Fertility preservation and pregnancy in cancer patients
F. Peccatori, IT
18:25   Discussion

 

24 April

8:30   Clinical session Lung cancer
Chair: R. Stahel, CH - Co-Chair: C. Rolfo, US
    Advanced NSCLC with oncogenic driver mutation
C. Rolfo, US
    Discussion
    Advanced Discussion NSCLC without oncogenic driver mutation
R. Stahel, CH
    Mutimodality treatment of stage III and oligometastatic NSCLC
C. Rolfo, US
    Discussion
    Multimodality therapy of small cell lung cancer
R. Stahel, CH
    Discussion
10:30   Coffee break
10:50   Selected participants present their national situation ("How is cancer treated in my country")
11:00   Discussion
11:10   Tumour board Lung cancer
R. Stahel, CH - C. Rolfo, US - C. Martin, AR
    Participant's case presentations
13:00   Lunch
14:35   Spotlight session Title to be confirmed
F. Cavalli, CH
 14:25   Discussion
 14:35   Group sessions
Chair: R. Stahel, CH - Co-Chair: C. Martin, AE
Chair 2: C. Rolfo, US - TBC
Clinical case presentations by participants
 16:35   Coffee break
16:55   Spotlight session How to fight financial toxicity
R. Stahel, CH
17:20   Discussion
17:30   Spotlight session Cancer of unknown primary
N. Pavlidis, GR
17:50   Discussion

 

 25 April

8:30   Clinical session Gastro-intestinal tumours
Chair: E. Van Cutsem, BE - Co-chair: A. Cervantes, ES
    What you have to obtain from the pathologists to make a good treatment decision
F. Penault-Llorca, FR
    Discussion
    Adjuvant and neo-adjuvant treatment of colorectal cancer
E. Van Cutsem, BE
    Discussion
    Systemic treatment in advanced CRC
E. Van Cutsem, BE
    Discussion
    Management of early rectal Cancer
A. Cervantes, ES
    Discussion
10:30   Coffee break
10:50   Treatment of early esophageal and gastric cancer
A. Cervantes, ES
    Discussion
    Systemic treatment of advanced gastric cancers
E. Van Cutsem, BE
    Discussion
    Systemic treatment of pancreatic and biliary tract cancer
E. Van Cutsem, BE
    Discussion
12:20-   Selected participants present their national situation ("How is cancer treated in my country")
12:30   Discussion
12:40   Tumour board Gastro-intestinal tumours
A. Cervantes - E. Van Cutsem – Tutor: S. Iseas, AR
Participant's case presentations
13:40   Lunch
14:30   -15:00 Spotlight session Principles of geriatric oncology
M. Aapro, CH
14:50   Discussion
15:00   Group sessions
Chair 1: A. Cervantes, ES - Co-chair: S. Iseas, AR
Chair 2: E. Van Cutsem, BE - Co-chair: F. Esteso, AR
Part Clinical case presentations by participants
17:00   Coffee break
17:20   Spotlight session How to operate colon cancer (video)
17:45   Discussion
20:15   Farewell Dinner

 

 26 April

8:00   Clinical session Genito-urinary Cancers
Chair: N. Mottet, FR, BE - Co-chair: J.P. Sadé
    Management of localized prostate cancer
N. Mottet, FR
    Discussion
    Treatment of metastatic castration sensitive prostate cancer
J.P. Sadè, AR
    Discussion
    Castration-resistant prostate cancer
N. Mottet, FR
    Discussion
    Treatment of bladder cancer
J.P. Sadè, AR
    Discussion
    Metastatic renal cancer: Evidence-based treatment
N. Mottet, FR
    Discussion
10:30   Coffee break
10:50   Tumour board Genito-urinary cancers
N. Mottet, FR - J.P. Sadè, AR - Tutor: M. Chacon, AR
Participant's case presentations
11:50   Group sessions
Chair 1: N. Mottet, FR - Co-Chair: M. Chacon, AR
Chair 2: J.P. Sadè, AR - Co-Chair: TBC
Part Clinical case presentations by participants
13:00   Learning assessment test
14:00   Closing Remarks and Awards
14:15   Lunch followed by departures

 

Follow us